2.85 USD
+0.07 (+2.52%)
2.7433 USD
-0.11 (-3.74%)
WHWK gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 525 industry peers in the Biotechnology industry. No worries on liquidiy or solvency for WHWK as it has an excellent financial health rating, but there are worries on the profitability. WHWK has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- WHWK had negative earnings in the past year.
- In the past year WHWK has reported a negative cash flow from operations.
- In the past 5 years WHWK always reported negative net income.
- WHWK had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
- WHWK has a Return On Assets of -9.35%. This is amongst the best in the industry. WHWK outperforms 84.38% of its industry peers.
- WHWK has a Return On Equity of -9.94%. This is amongst the best in the industry. WHWK outperforms 87.43% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -9.35% | ||
| ROE | -9.94% | ||
| ROIC | N/A |
ROA(3y)-57.7%
ROA(5y)-50.49%
ROE(3y)-74.03%
ROE(5y)-62.56%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- WHWK has a better Gross Margin (89.22%) than 91.24% of its industry peers.
- WHWK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 89.22% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
- WHWK does not have a ROIC to compare to the WACC, probably because it is not profitable.
- WHWK has more shares outstanding than it did 1 year ago.
- WHWK has more shares outstanding than it did 5 years ago.
- WHWK has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 4.47 indicates that WHWK is not in any danger for bankruptcy at the moment.
- WHWK has a Altman-Z score of 4.47. This is in the better half of the industry: WHWK outperforms 71.81% of its industry peers.
- There is no outstanding debt for WHWK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.47 |
ROIC/WACCN/A
WACC8.9%
2.3 Liquidity
- A Current Ratio of 16.76 indicates that WHWK has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 16.76, WHWK belongs to the best of the industry, outperforming 93.52% of the companies in the same industry.
- WHWK has a Quick Ratio of 16.76. This indicates that WHWK is financially healthy and has no problem in meeting its short term obligations.
- WHWK has a Quick ratio of 16.76. This is amongst the best in the industry. WHWK outperforms 93.52% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 16.76 | ||
| Quick Ratio | 16.76 |
3. Growth
3.1 Past
- WHWK shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.65%, which is quite good.
- Looking at the last year, WHWK shows a very negative growth in Revenue. The Revenue has decreased by -42.62% in the last year.
- Measured over the past years, WHWK shows a very strong growth in Revenue. The Revenue has been growing by 185.21% on average per year.
EPS 1Y (TTM)9.65%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%43.48%
Revenue 1Y (TTM)-42.62%
Revenue growth 3Y185.21%
Revenue growth 5YN/A
Sales Q2Q%-100%
3.2 Future
- The Earnings Per Share is expected to grow by 12.78% on average over the next years. This is quite good.
- WHWK is expected to show a very negative growth in Revenue. In the coming years, the Revenue will decrease by -14.87% yearly.
EPS Next Y88.14%
EPS Next 2Y19.73%
EPS Next 3Y12.78%
EPS Next 5YN/A
Revenue Next Year-72.66%
Revenue Next 2Y-41.42%
Revenue Next 3Y-25.99%
Revenue Next 5Y-14.87%
3.3 Evolution
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- The Price/Earnings Ratio is negative for WHWK. In the last year negative earnings were reported.
- Also next year WHWK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- WHWK's earnings are expected to grow with 12.78% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y19.73%
EPS Next 3Y12.78%
5. Dividend
5.1 Amount
- WHWK does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
WHITEHAWK THERAPEUTICS INC / WHWK FAQ
What is the fundamental rating for WHWK stock?
ChartMill assigns a fundamental rating of 4 / 10 to WHWK.
What is the valuation status of WHITEHAWK THERAPEUTICS INC (WHWK) stock?
ChartMill assigns a valuation rating of 0 / 10 to WHITEHAWK THERAPEUTICS INC (WHWK). This can be considered as Overvalued.
How profitable is WHITEHAWK THERAPEUTICS INC (WHWK) stock?
WHITEHAWK THERAPEUTICS INC (WHWK) has a profitability rating of 2 / 10.
What is the expected EPS growth for WHITEHAWK THERAPEUTICS INC (WHWK) stock?
The Earnings per Share (EPS) of WHITEHAWK THERAPEUTICS INC (WHWK) is expected to grow by 88.14% in the next year.